We have previously described the oncolytic adenovirus, Ad(CgA-E1A-miR122), herein denoted Ad5(CgA-E1A-miR122) that selectively replicates in and kills neuroendocrine cells, including freshly isolated midgut carcinoid cells from liver metastases. Ad5(CgA-E1A-miR122) is based on human adenovirus serotype 5 (Ad5) and infects target cells by binding to the coxsackieadenovirus receptor (CAR) and integrins on the cell surface. Some neuroendocrine tumor (NET) and neuroblastoma cells express low levels of CAR and are therefore poorly transduced by Ad5. However, they often express high levels of somatostatin receptors (SSTRs). Therefore, we introduced cyclic peptides, which contain four amino acids (FWKT) and mimic the binding site for SSTRs in the virus fiber knob. We show that FWKT-modified Ad5 binds to SSTR 2 on NET cells and transduces midgut carcinoid cells from liver metastases about 3-4 times better than non-modified Ad5. Moreover, FWKT-modified Ad5 overcomes neutralization in an ex vivo human blood loop model to greater extent than Ad5, indicating that fiber knob modification may prolong the systemic circulation time. We conclude that modification of adenovirus with the FWKT motif may be beneficial for NET therapy.
INTRODUCTION
Neuroendocrine tumors (NETs) are rare cancers with approximately 2/3 of lesions occurring in the gastrointestinal tract and 1/3 in the lower respiratory tract. 1 They are by tradition known as carcinoids and divided based on their embryonic origin into foregut (thymus, lung and gastroduodenal mucosa), midgut (jejunum, ileum, appendix and proximal colon) and hindgut (descending colon and rectum). The majority of NET cells express somatostatin receptors (SSTRs), which are G-protein-coupled plasma membrane receptors. There are five SSTRs, denoted as SSTR 1À5 , which exert various functions. Activation of SSTRs on NET cells results in growth inhibition. 2,3 Somatostatin, the natural ligand for SSTRs exists in two forms: one of 14 amino acids (SST-14) and one of 28 amino acids (SST-28). As a result of their short plasma half-life they are not useful clinically and stable synthetic analogues have been developed for clinical applications. The synthetic analogues are generally designed to retain the natural Phe-Trp-Lys-Thr (FWKT) loop of somatostatin, which contains the binding site for SSTRs. 4 Octreotide, the first synthetic somatostatin analog available for clinical use, binds with highest affinity to SSTR 2 , intermediate affinity to SSTR 3 and SSTR 5 , and minimal or no affinity to SSTR 1 and SSTR 4 . Radiolabeled somatostatin analogues have become important diagnostic tool in patients with suspected or recurrent neuroendocrine malignancies. 2, 5 They are also use as a therapeutic agent against NETs and neuroblastomas. 6, 7 Oncolytic viruses are emerging therapeutic agents for cancer. 8 Results from clinical trials show that they are safe but that the delivery and transduction efficiency of target cells need to be improved in order to fulfill therapeutic goals. We have previously described the oncolytic adenovirus, Ad(CgA-E1A-miR122) where E1A gene expression is driven by the human chromogranin A (CgA) promoter and further controlled by six tandem repeats of miR122 target sequences in the 3¢UTR of E1A. 9, 10 This virus selectively replicates in and kills neuroendocrine cells, including freshly isolated midgut carcinoid cells from liver metastases. However, it does not kill normal hepatocytes. Herein the virus is denoted Ad5(CgA-E1A-miR122) to clarify that it is based on human adenovirus serotype 5 (Ad5) and infects cells according to the natural Ad5 tropism. The fiber knob of Ad5 binds to the coxsackie-adenovirus receptor (CAR) on target cells. 11 Thereafter, virus pentons at the fiber base interacts with avb3 and avb5 integrins, leading to internalization of the virus, which is followed by partial degradation of the viral particle and transfer of the viral genome into the nucleus of the target cell. Several studies demonstrate loss of CAR expression on tumor cells, and thereby intrinsic resistance of tumor cells to treatment with oncolytic Ad5 viruses. 12, 13 The adenovirus tropism can be modified through genetic modification of the capsid to target receptors that are highly expressed on tumor cells and thereby avoid CAR deficiency. 14, 15 In this study, we investigate Ad5 vectors with fibers modifications for their ability to transduce NET cells. We evaluate an Ad5 with fiber from human adenovirus serotype 35 (Ad5f35), which binds to the CD46 receptor 16 and an Ad5 with fiber knob from human adenovirus serotype 3 (Ad5fk3), which binds to desmoglein 2 (DSG2). 17 In order to selectively target SSTRs and thereby infect NET cells, we incorporate the binding motif of octreotide (FWKT) into the HI loop of the Ad5 fiber knob. The FWKT-modified adenovirus shows increased transduction efficiency as well as strong wild-type like replication and killing in freshly isolated carcinoid cells and it is partly detargeted from neutralizing anti-Ad5 antibodies (NAbs) in human blood.
RESULTS

High expression of SSTRs in primary midgut carcinoid cells
Carcinoid cells obtained from patient tumor material as well as NET and neuroblastoma cell lines were evaluated by flow cytometry for expression of cell surface receptors involved in Ad5 attachment (CAR), Ad5f35 attachment (CD46) and Ad5fk3 attachment (DSG2) as well as adenovirus internalization (avb3 and avb5 integrins), (Table 1 ). The data indicate that it may be advantageous to use fibers from Ad3 and Ad35 for transduction of NET cells. However, CD46 is a complement regulatory protein expressed on all nucleated human cells, which may increase transduction of unwanted cells. DSG2 is a component of the cell-cell adhesion structure, which may cross-talk with the CAR molecule within junctional complexes. 18 Similarly to CAR, DSG2 expression has been found in normal epithelial tissues and epithelial cancers. Considering the fact that CAR is often downregulated in tumors, more studies are needed to investigate DSG2 expression pattern in human cancers. SSTR 1 , SSTR 2 , SSTR 3 and SSTR 5 are often highly expressed on NET cells so next we investigated the RNA expression levels on our samples and cell lines by quantitative real-time PCR (Figure 1a ). Freshly isolated midgut carcinoid cells (M3livmet, M4livmet and M4mesmet) express high levels of SSTR 2 with approximately 5-fold higher expression than foregut carcinoid cells (F1livmet and F2livmet) and 10-fold higher than the NET cell lines BON and CNDT2.5 and the neuroblastoma cell lines SH-SY-5Y and SK-N-BE(2). The normal fibroblast cell line 1064SK and the melanoma cell line mel526 are negative for SSTR 2 and included as negative controls. SSTR 1 expression is approximately 10-fold lower than SSTR 2 in the carcinoid samples while it is not expressed in the cell lines. SSTR 3 and SSTR 5 are expressed at a lower degree, especially in the foregut carcinoid samples. Higher expression of SSTR in midgut carcinoid cells than in foregut carcinoid cells and the cell lines was confirmed at the protein levels by the [ 125 I]Tyr 11 -somatostatin binding assay (Figure 1b) . Specific binding is seen for all cells, because the binding is competed by high concentration of non-radiolabeled somatostatin. However, expression of SSTR seems rather low in all cell lines as well as in the foregut carcinoma cell F2livmet   51  24  3  2  29  24  47  20 32  10   Midgut carcinoid   M3livmet   2  14  1  1  2  2  91  37  1  4   Midgut carcinoid   M4livmet   12  9  1  1  2  1  68  18  2  3   Midgut carcinoid   M4mesmet   8  6  2  1  2  1  66  15  1  1   BON  52  87  8 31  1  1  92 129 59 121   CNDT2.5  1  6  4 14  45  11  95  34 83 101  SK-N-BE(2)  15  15  61 83  19  13  26  22  4  8   SH-SY-5Y  60 103  4 17  20  19  1  6  4  7  mel526  17  5  11  5  89  57  7  2  4  16   1064SK  9  8  79 26  83  26  91  29  1  1  Hepatocytes  63  24 100 15  12  6  63  29 ND A recombinant adenoviral vector with FWKT motif in the fiber knob interacts with SSTR 2 and specifically transduces SSTR-positive NET and neuroblastoma cells All adenoviral vectors used in this study, and their characteristics, are presented in Table 2 . The vectors have surface modifications, which influence their transduction capacity and a titration method based on plaque-forming or fluorescence-forming unit assays would depend on the receptor expression on the cell line used for titration. Instead we chose a new titration method based on quantitative real-time PCR, similar to the method developed by Wold et al. 19 We designed primers for the adenoviral E4 orf1 gene to detect intact encapsidated viral genome (evg) of the purified vectors in order to determine their titers. That way a fair comparison can be made between the various vectors. We constructed a recombinant adenoviral vector with cyclic peptides with FWKT motifs in the fiber knob, Ad5fk FWKT (green fluorescent protein (GFP)), and investigated its interaction with SSTR 2 using Duolink in situ proximity ligation assay (PLA) technology (Figure 2a (Figures 2f and g ). Our data show that incorporation of FWKT in the HI loop of the fiber knob of Ad5 yields binding to SSTR 2 and partly blocks binding to CAR. In addition, by using the in situ PLA assay, we confirmed specific binding of Ad5f35(GFP) to CD46 and Ad5fk3(GFP) to DSG2 (Supplementary Figures S1a-d) .
To further examine the role of SSTR 2 and CAR in the transduction of FWKT-modified and unmodified adenoviral vectors, we performed blocking analysis using either SST-14 to compete with SSTR 2 -mediated uptake or CAR receptor knockdown (CXADR small interfering RNA) to reduce CAR-mediated uptake. Pre-incubation of BON with SST-14 blocked as expected Ad5fk FWKT (GFP) but not Ad5(GFP) transduction (Supplementary Figure S2a) . Transfection of BON with CAR small interfering RNA, resulted in inhibition of Ad5(GFP) transduction in a dose-dependent manner, while transduction of Ad5fk FWKT (GFP) was not affected, (Supplementary Figure S2b) . Downregulation of CAR receptor protein after CAR small interfering RNA transfection was confirmed by western blot analysis (Supplementary Figure S2c ).
An FWKT-modified Ad5 vector is superior to a non-modified vector in transduction of primary carcinoid cells and NET cell lines
Ad5fk FWKT (GFP) transduction (50 evg per cell) of midgut carcinoid cells from liver metastases (M4livmet and M3livmet) was 3-4 times more efficient than Ad5(GFP) and Ad5fk3(GFP) transduction and similar to transduction with Ad5f35(GFP). Ad5fk FWKT (GFP) transduction (50 evg per cell) of foregut carcinoid cells from liver metastases (F1livmet and F2livmet) was more efficient than Ad5(GFP), while Ad5f35(GFP) was the most efficient ( Figure 3a) . Importantly, Ad5fk FWKT (GFP) transduction of normal hepatocytes (500 evg per cell), both with or without blood coagulation factor X (FX), was still less efficient ( Figure 3b ) than Ad5fk FWKT (GFP) transduction of midgut carcinoid cells (50 evg per cell), (Figure 3a ). Ad5fk FWKT (GFP) yielded higher transduction efficacy than Ad5(GFP) in CNDT2.5 and SK-N-BE(2) and similar transduction efficacy in BON and SH-SY-5Y ( Figure 3c ). As expected, the SSTR-negative melanoma cell line mel526 and normal fibroblasts 1064SK were transduced to a lesser degree by Ad5fk FWKT (GFP) than by Ad5(GFP), (Figure 3d ). Importantly, we found that primary carcinoid cells are easier to transduce The FWKT-modified adenovirus exhibits enhanced oncolytic ability We next modified the oncolytic Ad5(CgA-E1A-miR122) virus by including FWKT motifs in the HI loop of the fiber knob to create Ad5fk FWKT (CgA-E1A-miR122). We examined the lytic ability of the FWKT-modified by using an MTS ([3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay on BON, SH-SY-5Y, SK-N-BE(2) and mel526. Primary carcinoid cells are not eligible for the MTS assay because of their low metabolic activity. CNDT2.5 was not included because CgA is not expressed in this cell line, as shown in Supplementary Figure S3 , and therefore the CgA promoter is not supported. Cells were transduced at evg ranging from 0.001 to 100. As expected, Ad5wt was most efficient in killing all cell lines (Figure 4a ). Ad5fk FWKT (CgA-E1A-miR122) was significantly more efficient than Ad5(CgA-E1A-miR122) in killing NET cells, which is most likely due to increased viral infectivity. Importantly, neither Ad5fk FWKT (CgA-E1A-miR122) nor Ad5(CgA-E1A-miR122) killed the negative control cell line mel526. We also evaluated virus replication by quantitative real-time PCR analysis, measuring genomic viral DNA (E4 orf1) copies 48 h after transduction. Replication index was defined as the increase in copy number of progeny viral DNA at 48 h compared with the copy number obtained 2 h after transduction (set to 1). The wild-type Ad5 virus (Ad5wt) replicated in all cell types examined, while AdMock did not, (Figure 4b ). Ad5fk FWKT (CgA-E1A-miR122) and Ad5(CgA-E1A-miR122) replication was as efficient as Ad5wt and yielded 200-700 progeny virions both in midgut and foregut carcinoid samples and in the NET and neuroblastoma cell lines (Figure 4b ). Importantly, in normal hepatocytes and the negative control cell line mel526 both Ad5fk FWKT (CgA-E1A-miR122) and Ad5(CgA-E1A-miR122) were strongly attenuated while Ad5wt replicated well (Figure 4b ). We next wanted to examine if the replication of Ad5fk FWKT (CgA-E1A-miR122) in NET cells resulted in production and release of progeny viruses. The presence of progeny viruses was verified by adding supernatants collected from infected primary carcinoid cells (F2 livmet and M3liv-met), BON, SH-SY-5Y and SK-N-BE(2) onto 911 cells followed by staining for adenoviral hexon proteins 24 h later (Supplementary Figure S4a) . Supernatant collected from the negative control cell line mel526 did not yield any progeny virus (Supplementary Figure S4a) . Furthermore, an MTS cell viability assay using the supernatants on 911 cells confirmed lytic ability of newly produced viruses from NET cells but not from the melanoma cell line (Supplementary Figure S4b) .
Fiber modification can protect adenovirus from neutralization in whole human blood A high proportion of the human population has been infected with Ad5 and has consequently preformed antibodies against the virus. 20, 21 This is thought to hamper clinical applications of Ad5-based vaccines and oncolytic Ad5 viruses. 22, 23 Therefore, we evaluated the recombinant GFP-expressing, fiber-modified Ad5 vectors in a newly developed human blood loop system. 24 Viruses were mixed with whole blood or medium and incubated in heparin-coated polyvinyl chloride tubing at 37 1C while rotating. We used blood from six healthy donors (D); four with low ability to neutralize Ad5 (D1, D2, D5 and D6) and two with high neutralizing ability (D3 and D4), to study the degree of neutralization in whole blood by adding the virus/blood sample dilutions to 911 cells and measuring GFP expression the day after. The titers obtained after 15 min and 6 h of incubation in blood were related to the titer of viruses incubated with medium, which was defined as 1. We found that the infectious capacity of Ad5fk FWKT (GFP) was significantly higher than Ad5(GFP) after 15 min of incubation in human blood, indicating prolonged circulation in the blood and partial escape from clearance ( Figure 5a , upper panel). Also after 6 h there was a trend, although not statistically significant that Ad5fk FWKT (GFP) retained higher infectious capacity than Ad5(GFP) (Figure 5a , lower panel). There was also a trend that Ad5fk3(GFP) retained higher infectious capacity than Ad5(GFP) both after 15 min and 6 h of incubation in human blood (Figure 5a ). Next, we examined the proportions of viruses associated with blood cells and plasma. Blood samples in the blood loop were incubated with the different viruses for 15 min where after blood cell and plasma was separated by centrifugation. Viral DNA was isolated from the two fractions and detected by quantitative real-time PCR. As expected, 490% of Ad5(GFP) was found in the cell fraction in all blood samples. In blood samples, especially in the ones with low ability to neutralize Ad5 (D1, D2, D5 and D6), Ad5f35(GFP), Ad5fk3(GFP) and Ad5fk FWKT (GFP) have tendencies to retain in the plasma although the highest proportion is still found in the cell fraction, Figure 5b , indicating that fiber knob-modified Ad5 binds less to CAR on erythrocytes.
DISCUSSION
We have previously described the neuroendocrine-selective oncolytic adenovirus, Ad5(CgA-E1A-miR122), which effectively kills NET cells, leaving non-cancerous cells such as normal hepatocytes unharmed. 9, 10 The aim of this study was to combine transcriptional and transductional targeting and to introduce a cyclic peptide (CDCFWKTCFC) in the virus fiber knob to selectively target Ad5 infection to neuroendocrine cells. The peptide sequence was chosen from octreotide, a stable synthetic somatostatin analogue that binds with high affinity to SSTR 2 , which is abundantly expressed on carcinoid cells. We choose to insert the peptide in the HI loop of the Ad5 fiber knob at the same position where the cyclic peptide (CDCRGDCFC) has successfully been introduced for targeting Ad5 to integrins. [25] [26] [27] The FWKTmodified viruses were as stable as the non-modified viruses both at 4 and 37 1C.
Ad5fk FWKT (CgA-E1A-miR122) showed strong replication and efficient killing of the carcinoid cell line BON and the neuroblastoma cell lines SH-SY-5Y and SK-N-BE(2) than did Ad5(CgA-E1A-miR122). More importantly, we confirmed efficient replication of Ad5fk FWKT (CgA-E1A-miR122) in carcinoid cells from liver metastases. We were unable to use MTS assay to visualize direct cell killing of freshly isolated carcinoid cells. However, we confirmed production of infectious progeny viruses from infected carcinoid cells as a result of viral replication. Figure 4 The FWKT-modified adenovirus exhibits enhanced oncolytic ability (a) The NET cell line BON, the neuroblastoma cell lines SK-N-BE(2) and SH-SY-5Y and melanoma cell line mel526 were transduced with oncolytic viruses at various evg per cell (0.001-1000). Cell viability was examined 6 days after transduction (for BON after 4 days). Cell viability values were expressed in relation to the viability of untransduced cells. Average enzymatic activities from three experiments each with triplicate samples are shown (mean ± s.d.). (b) Foregut and midgut carcinoid cells from liver metastases (livmet) were transduced at 50 evg per cell. Normal human hepatocytes were transduced at 500 evg per cell. BON, SK-N-BE(2), SH-SY-5Y and mel526 were transduced at 100 evg per cell. Viral DNA was isolated 2 h and 2 days after transduction. Quantitative real-time PCR was performed to measure E4 orf1 copies. Fold increase in DNA copies at day 2 is expressed in relation to DNA copies detected after 2 h (set as 1). *Po0.05 and **Po0.001.
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From the surface expression of SSTRs, as assessed by the [ 125 I]Tyr 11 -SSTR binding assay, we estimate that the expression level of SSTRs on midgut carcinoid cells from liver metastases is approximately five times higher than on the carcinoid cell lines. Therefore, one can predict that Ad5fk FWKT (CgA-E1A-miR122) would kill midgut carcinoid cells from clinical samples even more efficiently than carcinoid cell lines. Furthermore, by using the adenoviral vector Ad5fk FWKT (GFP) we could show that primary carcinoid cells required virus concentration of 50 evg per cell to achieve approximately 50% GFP-positive cells, while NET cell lines need to be transduced with 100-500 evg per cell to achieve the same effect. The biggest advantage for Ad5fk FWKT (GFP) over Ad5(GFP) is seen on cells, which are positive for SSTR 2 but has no or very low CAR expression, such as CNDT2.5. Ad5fk FWKT (GFP) is approximately equally efficient in all NET and neuroblastoma cells lines, which corresponds well to their SSTR 2 expression. We also found that Ad5f35 and Ad5fk3 are better than Ad5 in transducing carcinoid cells isolated from surgery samples. However, Ad5f35 and Ad5fk3 fall short of Ad5fk FWKT in all cases except for the CNDT2.5 cell line. Overall, transduction efficiencies follow what could be expected from the target cell expression of CAR, CD46, DSG2 and SSTRs. We did not have access to freshly isolated neuroblastoma cells but efficient killing of neuroblastoma cell lines indicates that the virus is also potentially efficient for neuroblastomas.
Carcinoids form metastases in the liver and oncolytic adenovirus treatment could be applied as intrahepatic or intratumoral injections. Therefore, it is important that virus activity is low in normal hepatic cells to minimize unwanted toxicity. We have previously utilized both transcriptional (promoter) and post-transcriptional (microRNA target sequences) targeting to suppress virus activity in liver cells. 10 An alternative approach to suppress virus activity in liver cells is to redirect virus infectivity through capsid or fiber modifications as we now did with the FWKT-modified virus. It is attractive that Ad5fk FWKT (GFP) is less efficient than Ad5(GFP) to transduce normal hepatocytes, both in the presence and absence of blood coagulation factor FX. It has been reported that Ad5 uptake in the mouse liver is mediated by blood factors and does not depend on virus interaction with CAR receptor. 28 Efficient transduction of mouse liver cells after intravenous Ad5 injections raised concern about Ad-mediated hepatic toxicity. 29 However, studies on Ad5 interaction in human blood indicate that binding to erythrocytes has a greater role than interaction with blood coagulation factors. 24, 30 Moreover, data from clinical trials strongly indicate that systemic administration of Ad5 do not affect the liver to the same extent as has been observed in mouse models. 30, 31 Treatment with oncolytic Ads has been well tolerated and more importantly no significant liver toxicity has been reported to date after Ad infusions including numerous injections directly into the hepatic artery. 31 We demonstrated that FWKT modification in the fiber retargets adenovirus binding toward SSTR 2 . This was shown by PLA, which is a modern technology to study protein-protein interactions. 32, 33 PLA has been used in the past to detect parvovirus and an intracellular bacterium 34 and our data indicate that it may become an important tool to investigate and verify binding of native and modified viruses and other pathogen to cell surface molecules. The PLA assay also revealed that insertion of FWKT motif in the HI loop allowed for binding to SSTR 2 but did not completely abolish CAR binding. This was confirmed by transduction experiments together with SST competition and CAR knock-down. If complete detargeting from CAR is wanted, other strategies should be applied such as mutagenesis of CAR binding amino acids in the fiber knob 11 in conjunction with introducing of the targeting peptide in the HI loop 25 C-terminal of the fiber 35 or hexon. 36 Alternatively the fiber knob 14 or fiber 37 of Ad5 could be exchanged with an alternative serotype. The double binding of Ad5 FWKT (GFP) to SSTR 2 and CAR indicates that the adenoviral knob protein possesses a range of structural plasticity. 38 This may be beneficial for adenovirus therapy of neuroendocrine malignancies, where somatostatin analog treatment often desensitizes SSTRs and induce loss of cell surface receptors through ligand-induced endocy- Figure 5 FWKT-modified Ad5 partly escapes from neutralization in whole human blood and from association with blood cells. (a) GFP-expressing adenoviral vectors were incubated in the human blood loop system and samples were taken after 15 min and 6 h of incubation when the viral ability to infect 911 cells was examined. Infectivity was measured by detection of GPF expression by flow cytometry. The titers of each Ad vector exposed to blood were related to the titer of the same Ad vector incubated with medium, which was set as 1. (b) GFP-expressing adenoviral vectors were incubated with whole human blood for 15 min. Blood samples were taken, followed by isolation of the plasma and cell fractions by centrifugation. Viral DNA was extracted and quantified by quantitative real-time PCR. The percentage of plasma and cell-bound fractions is presented. *Po0.05.
tosis. 39 However, longer exposure to the SST ligand and its analogs can restore SSTRs functions and surface levels. 39, 40 Moreover, the ratio of internalized SSTRs to membranous SSTRs varies from one patient to the other, mainly due to active circulation of SSTRs regulated by various factors. 41 We examined the fiber knob-modified Ad5 vectors in the newly developed human blood loop model. 24 Ad5(GFP), Ad5f35(GFP), Ad5fk3(GFP) and Ad5fk FWKT (GFP) share the same capsid (hexon, penton, fiber base and shaft). Nevertheless, we observed that Ad5fk FWKT (GFP) has the ability to overcome neutralization to a certain degree after incubation in whole human blood. However, the capacity of human blood to neutralize surface-modified Ad5 is clearly individual because some blood samples goes against the trend. These data are in agreement with previous studies, suggesting that RGD or 5/3 modification of the Ad5 fiber knob can, at least partly, avoid neutralization from preexisting Ad5 NAbs. 42, 43 Ad5fk FWKT (GFP), Ad5f35(GFP) and Ad5fk3(GFP) show a tendency to remain in the plasma fraction, which may be explained by decreased interaction with CAR and complement receptor 1 on human erythrocytes. 30 Beneficial effects of fiber modification could not have been observed in a standard neutralization assay with heat-inactivated plasma, which strongly support the use of the ex vivo blood loop system as a more accurate preclinical model. Further studies are needed to fully understand adenovirus interaction with human blood components in order to design novel approaches to efficiently deliver therapeutic adenovirus to tumor tissues.
In conclusion, adenovirus with FWKT motifs in the fiber knob selectively infects SSTR 2 -positive neuroendocrine cells. The FWKTmodified oncolytic adenovirus Ad5(CgA-E1A-miR122) shows enhanced viral replication and strong wild-type like killing ability of neuroendocrine cells but not of non-neuroendocrine cells. Moreover, partial escape from preexisting NAb indicates ability of prolonged circulation in the blood and possibility for improved anti-tumor activity. Our data suggest that Ad5fk FWKT (CgA-E1A-miR122) is potentially useful as a specific agent for therapy of NET liver metastases.
MATERIALS AND METHODS
Ethics statement, isolation and culture of primary cells
Carcinoid specimens were obtained from patients who underwent liver surgery to remove midgut or foregut carcinoid metastases. A written consent statement was obtained from each patient. The experimental procedures have been approved by the Regional Ethical Committee, Uppsala University Hospital (ref. no. 2009/152 ). Isolation and culture conditions of carcinoid tumor specimens have been described earlier. 10 Human hepatocytes (Lot 281, 285 and 286) were purchased from BD Bioscience (San Jose, CA, USA) and (batch: HEP220507) from Biopredic International (Rennes, France).
Cell lines
The human endocrine pancreatic tumor cell line BON (a kind gift from Professors CM Townsend and JC Thompson, Galveston, TX, USA) was cultured in Dulbecco's modified Eagle's medium (DMEM) with Glutamax-I and F12 nutrient mixture (Kaighn's modification) at a ratio of 1:1, supplemented with 10% fetal bovine serum (FBS), 1 mM sodium pyruvate and 1% penicillin-streptomycin (PEST). The cell line CNDT2.5 (a kind gift from Professor LM Ellis, MD Anderson, Houston, TX, USA) was cultured in DMEM/F-12 medium, supplemented with 10% FBS, 1% non-essential amino acids, 1 mM vitamins, 3.2 mM L-glutamine, 1 mM sodium pyruvate, 1% PEST. The human neuroblastoma cell lines SH-SY-5Y and SK-N-BE(2) (a kind gift from Dr F Hedborg, Uppsala University, Uppsala, Sweden) were cultured in minimum essential medium with Earl's salt and L-glutamine, supplemented with 10% FBS, 1 mM sodium pyruvate, 1% PEST. The melanoma cell line mel526 (ATCC, Manassas, VA, USA) was cultured in Iscove's modification of Dulbecco's medium supplemented with 10% FBS, 1 mM sodium pyruvate, 1% PEST and 3.2 mM L-glutamine. The normal fibroblast cell line 1064SK (ATCC) was cultured in DMEM medium with 10% FBS, 1 mM sodium pyruvate, 1% PEST. The 911 cell line (Crucell, Leiden, The Netherlands) used for virus production was cultured in DMEM supplemented with 10% FBS, 1 mM sodium pyruvate, 1% PEST. All cell culture reagents were from Invitrogen (Carlsbad, CA, USA).
Recombinant adenoviruses
The recombinant adenoviruses in this study are E1B-deleted, based on human serotype 5 (Ad5), and constructed using the AdEasy technology. The transfer plasmids for the Ad5 E1 region have been described earlier: pShuttle-i/CgAE1AmiR122 (ref. 10 ) and pShuttle(CMV-GFP). 44 The Ad5 backbone plasmids have been described earlier: pAdEasy1 (ref. 45 ) and pAdEasy1-5/3-E3+. 14 A serotype 5 adenoviral vector with the fiber shaft and knob from serotype 35, Ad5f35(GFP), was a kind gift from Dr Fan (Lund University, Lund, Sweden) and has been described and evaluated before. 37, 46 New Ad5 backbone plasmids. The two primers Somatostatin.F: 5¢-CGAAGTG TGACTGCTTCTGGAAGACCTGTTTCTG-3¢ and Somatostatin.R: 5¢-CGCAG AAACAGGTCTTCCAGAAGCAGTCACACTT-3¢ were annealed and the product was cloned into the BstBI-ClaI site of pFiber, 27 kindly provided by Dr PJ Bosma (University of Amsterdam, Amsterdam, The Netherlands) to create pFiber-FWKT. The primer pair encodes the amino acid sequence: KCDCFWKTCFC. The pFiber plasmid contains the Ad5 fiber with the BstBI-ClaI site located in the sequence encoding the HI loop. 27 The adenovirus E3 sequence was subcloned/recombined from pBlue(E3) 47 using SpeI and NdeI into SrfI-linearized pAdEasy-Sce, 27 kindly provided by PJ Bosma, to create pAdEasy-Sce-E3. The FWKT-modified fiber sequence was then subcloned/ recombined from pFiber-FWKT using EcoRV and HpaI into I-Sce-1-linearized pAdEasy-Sce-E3, to create pAdEasy-Sce-E3-FWKT.
Recombinant viruses were produced in 911 cells, purified by CsCl banding and dialyzed against buffer containing 10 mmol l -1 Tris-HCL (pH 8.0), 2 mmol l -1 MgCl 2 and 4% sucrose. Infectious viral particles were determined by a fluorescence-forming unit assay 47 and evg titers were determined by quantitative real-time PCR using primers for E4 orf1: E4.For 5¢-CATCAGGTT GATTCACATCGG-3¢ and E4.Rev 5¢-AAGCGCTGTATGTTGTTCTG-3¢. A standard curve with threshold cycles (Ct) for 1Â10 3 -1Â10 7 copies of a plasmid containing the cloned PCR product (pCR2.1-E4orf1) was generated. Viralspecific PCR products were measured by the CFX96 real-time detection system (Bio-Rad, Hercules, CA, USA) using iQ SYBR Green supermix (Bio-Rad). The recombinant viruses and wild-type Ad5 (Ad5wt) were stored in aliquots in À80 1C.
Flow cytometry
Primary carcinoid cells and cell lines were analyzed by flow cytometry (FACSCalibur, BD Biosciences, San Diego, CA, USA) using the following antibodies: fluorescein isothiocyanate-labeled mouse anti-CD46 (BD Biosciences); mouse anti-integrin avb5 (Chemicon, Temecula, CA, USA), mouse anti-integrin avb3 (Chemicon), mouse anti-CAR (RmcB hybridoma, ATCC), mouse anti-DSG2 (BD Biosciences), secondary fluorescein isothiocyanatelabeled anti-mouse/anti-rabbit. Unspecific antibody bindings were analyzed by staining with isotype-matched fluorescein isothiocyanate-labeled control antibodies (BD Biosciences).
Analysis of SSTRs and CgA RNA expression
Total RNA from primary carcinoid cells, normal hepatocytes and cell lines was extracted by using RNeasy Mini Kit (QIAGEN, Hilden, Germany). RNA purity and concentration were determined by using Nanodrop 1000 (Thermo Scientific, Waltham, MA, USA). Total RNA was aliquoted and stored at À80 1C. Reverse transcriptase reactions were performed using 1 mg of total RNA of each sample by SuperScript II Reverse Transcriptase kit (Invitrogen). Complementary DNA (diluted 1:5) was used for quantitative reverse transcriptase-PCR together with the primers: SSTR1.F 5¢-AGTTGGTCTGCGC-GAAGATC-3¢; SSTR1.R 5¢-CGCGTCAGCAGCAAAGTG-3¢; SSTR2.F 5¢-TCAACGTTTCTTCCGTCTCCAT-3¢; SSTR2.R 5¢-GAGGACCACCACAAA GTCAAACA-3¢; SSTR3.F 5¢-TCTACGTGCTCAACATCGTCAA-3¢; SSTR3.R 5¢-TGGCACAGCTGTTGGCATAG-3¢; SSTR5.F 5¢-CATCCTCTCCTACGCCA ACAG-3¢; SSTR5.R 5¢-TGGAAGCTCTGGCGGAAGT-3¢; CgA.F 5¢-CCCCA CTGTAGTGCTGAACC-3¢; CgA.R 5¢-GGAGTGCTCCTGTTCTCCC-3¢; bactin.F 5¢-CGAGAAGATGACCCAGATCATG-3¢; b-actin.R 5¢-ACAGCCTGGA-TAGCAACGTACA-3¢. The PCR products were measured by CFX96 real-time detection system (Bio-Rad) using iQ SYBRGreen supermix (Bio-Rad). The data were evaluated using the 2 ÀDDCT method 48 and normalized against b-actin expression (set to 1).
Proximity ligation assay
The PLA assay was performed with the Duolink detection kit from Olink Bioscience (Uppsala, Sweden). Cells were cultured in Lab-Tek chambers (Thermo Scientific), washed (5 min, 2Âphosphate-buffered saline with 2.5 mM EDTA) and incubated with adenoviruses (1000 evg per cell) for 2 h at 4 1C. The cells were washed (5 min, 1Âphosphate-buffered saline), fixed with ice-cold 3% paraformaldehyde, permeabilized with 0.5% TritionX-100, washed (5 min, 3Âphosphate-buffered saline) and blocked with 1Â blocking solution (Olink Bioscience) for 2 h. Primary antibodies were: mouse monoclonal antiAd-hexon (Chemicon); rabbit polyclonal anti-CAR (Abgent Inc., San Diego, CA, USA); rabbit polyclonal anti-SSTR 2, 49 a kind gift from F Leu, Verto Institute LLC, The Cancer Institute of New Jersey, New Brunswick, NJ, USA; rabbit monoclonal anti-HA (Cell Signaling, Danvers, MA, USA), mouse monoclonal anti-DSG2 (BD Bioscience); mouse monoclonal anti-CD46 (BD Bioscience). Antibodies were diluted 1:50-1:400 in 1Â antibody diluent (Olink Bioscience) and incubated overnight at 4 1C. Secondary probes were diluted 1:10 in 1Â antibody diluent (Olink Bioscience) and incubated for 2 h at room temperature. The slides were counterstained with Hoechst 33342 (SigmaAldrich, St Louis, MO, USA) and Phalloidin 488 (Invitrogen) for 15 min at room temperature. After mounting with SlowFade medium (Invitrogen), the slides were examined with a Zeiss AxioPlan2 microscope equipped with a PlanNEOF Zeiss 40Â/1.32-0.6 oil objective. Images were acquired with an AxioCam MRm camera (Zeiss, Stockholm, Sweden). Fluorescence microscopy signals were quantified with the BlobFinder software, 50 a freely available image analysis tool for image cytometry. Cell nuclei and point-source fluorescence signals were defined and quantified by shape and fluorescence intensity according to the standard procedures for this software tool. Settings were kept constant within each experimental series. Background level (unspecific binding of antibodies) was established, for primary antibody and secondary probes on COS7, transfected with pEGFP-C2 or p3HA-SSTR 2 , and BON cells without incubation with the adenoviruses. Background level was also done also for each individual primary antibodies and secondary probes in order to evaluate the working concentrations.
Receptor-binding assay
[ 125 I]Tyr 11 -somatostatin (NEX389, Perkin Elmer, Waltham, MA, USA), was dissolved in MQ-water and diluted to 0.5 nM (18.5 kBq ml -1 ) in Quantum263 cell-culture media with L-glutamine (PAA Laboratories GmbH, Pasching, Austria). Cells grown in 12-well plates were rinsed once with culture media and thereafter incubated with 0.5 ml [ 125 I]Tyr 11 -somatostatin for 2 h at 4 1C. To verify receptor specificity some cells were co-incubated with 1.2 mM somatostatin (Sigma-Aldrich, S9129), for blocking [ 125 I]Tyr 11 -somatostatin binding to SSTR. The receptor binding was terminated by washing cells once with 5 ml and thereafter twice with 2 ml of cold serum-free culture media. Cells were then detached using 0.5 ml of Trypsin/EDTA for 15 min in 37 1C followed by resuspension in additional 1 ml culture media. Finally, cells were counted (Z2, Coulter Counter, Beckman, CA, USA) and cell-associated radioactivity was measured in an automated gamma counter (1480 Wallac Wizard, Perkin Elmer). Bound [ 125 I]Tyr 11 -somatostatin per cell was calculated.
Infectivity assay and incubation with blood coagulation FX
Cells were transduced in suspension with viruses at 50, 100 or 500 evg per cell. Two hours after transduction, cells were washed and plated in 24-well plates (2Â10 5 cells per well). Cells were harvested 2 days after transduction, followed by flow cytometry analysis of GFP-positive cells. Viruses were pre-incubated with or without FX (8 mg ml À1 ) for 30min at 371C. Adherent normal hepatocytes were then transduced with virus supernatant at a concentration of 500 evg per cell. Two hours after transduction, cells were washed and fresh medium was added. Cells were harvested 2 days later, followed by flow cytometry analysis of GFP-positive cells.
Replication assay
Primary foregut and midgut carcinoid cells were transduced in suspension with viruses at 50 evg per cell. Cell lines were transduced in suspension with viruses at 100 evg per cell. Two hours after transduction, cells were washed and plated in 24-well plates (2.5Â10 5 cells per well). For replication assay, cell were harvested directly (day 0) and 2 days after transduction, followed by viral DNA isolation using the High Pure Viral Nucleic Acid Kit (Roche Applied Sciences, Mannheim, Germany). Viral replication was detected by quantitative real-time PCR with primers for the adenoviral E4 orf1 transcript (section: Recombinant adenoviruses). Gene-specific PCR products were measured by the CFX96 real-time detection system (Bio-Rad) using iQ SYBR Green supermix (Bio-Rad). The data were evaluated using the 2 ÀDDCT method 48 using the DNA level of E4 orf1 from day 0 from each sample for normalization.
Progeny virus assay
The progeny virus assay was used subsequently to the replication assay to demonstrate that infectious progeny virus are formed and released on virus replication. Three days after transduction, the supernatants were collected and diluted 1:7. Diluted supernatants (100 ml) were added to confluent 911 cells in 96-well plates. Fresh medium was added after 2 h. A standard fluorescenceforming unit assay was performed after 24 h using a primary mouse monoclonal anti-Ad hexon antibody (Chemicon) and a secondary Alexa488-labeled goat polyclonal anti-mouse antibody (Invitrogen) followed by inspection of green cells in a fluorescence microscope (Olympus CK40, Tokyo, Japan) to detect progeny virus that had infected 911 cells. Furthermore, supernatants with progeny virus from the replication assay were collected after 2 days and used to infect 911 cells followed by the MTS cell titer 96 aqueous one solution cell proliferation assay (Promega, Madison, WI, USA) according to the manufacturer's instructions.
Cell viability assay
Cells were transduced in suspension with viruses at concentrations 0.01-1000 evg per cell. Two hours after transduction, the cells were plated in 96-well plates (1Â10 4 cells per well). Cell viability was analyzed 4 or 6 days after transduction using the MTS cell titer 96 aqueous one solution cell proliferation assay (Promega) according to the manufacturer's instructions. Cell viability values were expressed in relation to the viability of untransduced cells. Average enzymatic activities from three experiments each with triplicate samples are shown (mean ± s.d.).
Human blood loop model
Permit to collect blood from health donor was approved by the Regional Ethical Committee (ref. no. 2008/264). The ex vivo blood loop model for whole human blood has been described earlier. 24 Minor changes are that 0.5 U ml ml -1 of hirudin (LEO Pharma Nordic, Ballerup, Denmark) was immediately added to the venous blood in heparinized Falcon tubes. The blood was then transferred to heparin-coated polyvinyl chloride tubing, 21 cm long with an inner diameter of 4 mm (Corline, Uppsala, Sweden). Each loop was filled with 2 ml blood, followed by addition of 4Â10 9 evg of viral vector or phosphatebuffered saline as control.
Titration of infectious virus after blood exposure
Whole blood (55 ml) from the loop was taken after 15 min and 6 h, diluted from 1:10 to 1:10 000 in DMEM medium and added to confluent 911 cells in 24-well plates. After 2 h of incubation, the plates were washed once with medium, after which fresh medium was added and the incubation continued for 24 h. The cells were harvested and GFP expression was detected by flow cytometry (FACSCalibur) as a measurement of infection. The titers obtained after 15 min and 6 h of incubation were related to the titer of viruses not exposed to human blood, which was set to 1. volumes were adjusted to 200 ml with DMEM medium and viral DNA was purified from each fraction using the High Pure Viral Nucleic Acid Kit (Roche Applied Sciences). Copy numbers of viral DNA were detected by quantitative reverse transcriptase-PCR with primers for the adenoviral E4 orf1 transcript (section: Recombinant adenoviruses). Gene-specific PCR products were measured by iCycler IQ real-time detection system (Bio-Rad) using iQ SYBR Green supermix (Bio-Rad). To compare copy numbers in plasma and cell fractions, the results were adjusted according to the packed cell volume (hematocrit), which is 46% for men and 42% for women.
Statistical analysis
Significant differences of proximity ligation data, where the number of PLA signals per cell were evaluated using Wilcoxon Rank-Sum test, which is a nonparametric test for independent samples (GraphPad Software, San Diego, CA, USA), are denoted in the graphs as ***Po0.0001 and **Po0.001. For the cell viability (MTS assay), the values were found be normally distributed by the Shapiro-Wilk Normality test. Therefore, Student's t-tests were performed with *Po0.05, **Po0.001. For neutralization (titration of infectious virus after blood exposure) paired Wilcoxon Rank-Sum test was performed with *Po0.05.
